Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × canakinumab × 90 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 3 Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 83 Cyclophosphamide 56 Cisplatin 51 Nivolumab 41 Gemcitabine 33 Paclitaxel 32 Carboplatin 31 Radiotherapy 29 Dexamethasone 28 fludarabine 27 Blood Specimen Collection 27 Doxorubicin 20 Rituximab 18 Lenalidomide 18 Ipilimumab 18 Fluorouracil 18 Docetaxel 18 atezolizumab 17 Prednisone 17 Oxaliplatin 17 Irinotecan 17 Cetuximab 17 Trastuzumab 16 Surveys and Questionnaires 16 Biopsy 16 lenvatinib 15 durvalumab 15 Vincristine 15 Leucovorin 15 Cytarabine 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04028245 2026-04-15

SPARC-1

Columbia University

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡